🇺🇸 FDA
Pipeline program

ABI-4334 Tablet

ABI-4334-101

Phase 1 small_molecule completed

Quick answer

ABI-4334 Tablet for Chronic Hepatitis B is a Phase 1 program (small_molecule) at ASSEMBLY BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ASSEMBLY BIOSCIENCES, INC.
Indication
Chronic Hepatitis B
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials